Disclosures for "Sarcoidosis-Associated Small Fiber Neuropathy Responsive to Tocilizumab: A Case Series "
-
Dr. Aguilera Peña has nothing to disclose.
-
The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has a non-compensated relationship as a Board of Directors member with ACGME that is relevant to AAN interests or activities.
-
The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from American Academy of Neurology.